Cargando…

VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition

The use of computational tools for virtual screening provides a cost-efficient approach to select starting points for drug development. We have developed VSpipe, a user-friendly semi-automated pipeline for structure-based virtual screening. VSpipe uses the existing tools AutoDock and OpenBabel toget...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Carretero, Sandra, Pavlopoulou, Niki, Adams, James, Gilsenan, Jane, Tabernero, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017540/
https://www.ncbi.nlm.nih.gov/pubmed/29414924
http://dx.doi.org/10.3390/molecules23020353
_version_ 1783334773356232704
author Álvarez-Carretero, Sandra
Pavlopoulou, Niki
Adams, James
Gilsenan, Jane
Tabernero, Lydia
author_facet Álvarez-Carretero, Sandra
Pavlopoulou, Niki
Adams, James
Gilsenan, Jane
Tabernero, Lydia
author_sort Álvarez-Carretero, Sandra
collection PubMed
description The use of computational tools for virtual screening provides a cost-efficient approach to select starting points for drug development. We have developed VSpipe, a user-friendly semi-automated pipeline for structure-based virtual screening. VSpipe uses the existing tools AutoDock and OpenBabel together with software developed in-house, to create an end-to-end virtual screening workflow ranging from the preparation of receptor and ligands to the visualisation of results. VSpipe is efficient and flexible, allowing the users to make choices at different steps, and it is amenable to use in both local and cluster mode. We have validated VSpipe using the human protein tyrosine phosphatase PTP1B as a case study. Using a combination of blind and targeted docking VSpipe identified both new and known functional ligand binding sites. Assessment of different binding clusters using the ligand efficiency plots created by VSpipe, defined a drug-like chemical space for development of PTP1B inhibitors with potential applications to other PTPs. In this study, we show that VSpipe can be deployed to identify and compare different modes of inhibition thus guiding the selection of initial hits for drug discovery.
format Online
Article
Text
id pubmed-6017540
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60175402018-11-13 VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition Álvarez-Carretero, Sandra Pavlopoulou, Niki Adams, James Gilsenan, Jane Tabernero, Lydia Molecules Article The use of computational tools for virtual screening provides a cost-efficient approach to select starting points for drug development. We have developed VSpipe, a user-friendly semi-automated pipeline for structure-based virtual screening. VSpipe uses the existing tools AutoDock and OpenBabel together with software developed in-house, to create an end-to-end virtual screening workflow ranging from the preparation of receptor and ligands to the visualisation of results. VSpipe is efficient and flexible, allowing the users to make choices at different steps, and it is amenable to use in both local and cluster mode. We have validated VSpipe using the human protein tyrosine phosphatase PTP1B as a case study. Using a combination of blind and targeted docking VSpipe identified both new and known functional ligand binding sites. Assessment of different binding clusters using the ligand efficiency plots created by VSpipe, defined a drug-like chemical space for development of PTP1B inhibitors with potential applications to other PTPs. In this study, we show that VSpipe can be deployed to identify and compare different modes of inhibition thus guiding the selection of initial hits for drug discovery. MDPI 2018-02-07 /pmc/articles/PMC6017540/ /pubmed/29414924 http://dx.doi.org/10.3390/molecules23020353 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Álvarez-Carretero, Sandra
Pavlopoulou, Niki
Adams, James
Gilsenan, Jane
Tabernero, Lydia
VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition
title VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition
title_full VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition
title_fullStr VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition
title_full_unstemmed VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition
title_short VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition
title_sort vspipe, an integrated resource for virtual screening and hit selection: applications to protein tyrosine phospahatase inhibition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017540/
https://www.ncbi.nlm.nih.gov/pubmed/29414924
http://dx.doi.org/10.3390/molecules23020353
work_keys_str_mv AT alvarezcarreterosandra vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition
AT pavlopoulouniki vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition
AT adamsjames vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition
AT gilsenanjane vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition
AT tabernerolydia vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition